Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?

Gilchrist F.J., France M., Bright-Thomas R., Doherty C.J., Govan J.R., Webb A.K., Jones A.M.

Source: Eur Respir J 2011; 38: 1483-1486
Journal Issue: December
Disease area: Respiratory infections

Full text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Gilchrist F.J., France M., Bright-Thomas R., Doherty C.J., Govan J.R., Webb A.K., Jones A.M.. Can transmissible strains of Pseudomonas aeruginosa be successfully eradicated?. Eur Respir J 2011; 38: 1483-1486

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Host response to transmissible Pseudomonas aeruginosa
Source: Eur Respir J 2004; 23: 493-494
Year: 2004


Characterization of the resistance mechanisms to carbapenems and virulence genes in Pseudomonas aeruginosa strains from children with cystic fibrosis.
Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects
Year: 2021


Dental units as infection sources of Pseudomonas aeruginosa
Source: Eur Respir J 2008; 32: 1122-1123
Year: 2008


Variation in hydrogen cyanide production between different strains of Pseudomonas aeruginosa
Source: Eur Respir J 2011; 38: 409-414
Year: 2011



Omics-based tracking of Pseudomonas aeruginosa persistence in “eradicated” cystic fibrosis patients
Source: Eur Respir J, 57 (4) 2000512; 10.1183/13993003.00512-2020
Year: 2021



The impact of testosterone on Pseudomonas aeruginosa pathogenicity and antimicrobial susceptibility
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018

Can LCI predict new Pseudomonas aeruginosa colonization among CF patients?>
Source: International Congress 2017 – What is the future for paediatric respiratory physiology and sleep?
Year: 2017



Newly acquired pseudomonas aeruginosa in Belgian cystic fibrosis-patients: does the patients‘ P. aeruginosa genotype correlate with environmental genotypes?
Source: Eur Respir J 2006; 28: Suppl. 50, 485s
Year: 2006

Enterobacteriaceae and Pseudomonas aeruginosa in community-acquired pneumonia: the reality after a decade of uncertainty?
Source: Eur Respir J 2010; 35: 473-474
Year: 2010


Multiresistant bacterial infections
Source: School Course 2012 - Lung Transplantation
Year: 2012



Respiratory commensal streptococcus spp do not modulate the outcome of pseudomonas aeruginosa infection in vivo
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016

Macrolide resistance in Pseudomonas aeruginosa: implications for practice
Source: Eur Respir J, 49 (5) 1700689; 10.1183/13993003.00689-2017
Year: 2017



Streptococcus pneumoniae inhibits Pseudomonas aeruginosa growth on nasal human epithelium in vitro
Source: International Congress 2018 – New therapies for respiratory infections: experimental and translational studies
Year: 2018

Pseudomonas aeruginosa and legionella pneumophilia in water of dental units
Source: Eur Respir J 2006; 28: Suppl. 50, 486s
Year: 2006

Effects of direct lung dosing of Tobramycin in a rat chronic infection model using Pseudomonas aeruginosa RP73
Source: International Congress 2018 – Mechanisms of respiratory infection
Year: 2018


Variability of ß-lactamase resistance Pseudomonas aeruginosa genes infecting patients with cystic fibrosis
Source: Virtual Congress 2021 – Back to infection basics
Year: 2021


Persistence and genetic adaptation of Pseudomonas aeruginosa in patients with COPD.
Source: Virtual Congress 2020 – Airway infection: the microbiome and beyond
Year: 2020